Skip to main content
. 2024 Feb 26;43:101918. doi: 10.1016/j.tranon.2024.101918

Fig. 9.

Fig. 9

The association of risk scores with mutations in clinical prognostic models. (A, B) Waterfall plots of tumor body mutations established in high- and low-risk patients. (C) The association of MSI with the risk scores of the clinical prognostic models.